Insider · CIK 0001055919

DUGGAN ROBERT W

Reports to the SEC for 5 companies · HAYWARD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001055919

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-12	SMMTSummit Therapeutics Inc.P Purchase	Director, Co-Chief Executive Officer, 10% Owner	PPurchase	+3.81M sh	$13.12	+$50M	573,883,879
2026-06-11	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+12.5K sh	—	—	12,495
2026-06-11	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+30K sh	—	—	30,000
2026-06-04	SMMTSummit Therapeutics Inc.P Purchase	Director, Co-Chief Executive Officer, 10% Owner	PPurchase	+100K sh	$14.60	+$1.46M	25,824,474
2026-05-11	PLSEPULSE BIOSCIENCES, INC.P Purchase	Director, 10% Owner	PPurchase	+660K sh	$19.69	+$13M	48,211,433
2026-05-11	PLSEPULSE BIOSCIENCES, INC.P Purchase	Director, 10% Owner	PPurchase	+660K sh	$19.69	+$13M	48,370,047
2026-01-02	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+11.2K sh	$8.76	+$98.4K	11,232
2025-10-21	SMMTSummit Therapeutics Inc.A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+267K sh	$18.74	+$5M	25,724,474
2025-10-21	SMMTSummit Therapeutics Inc.A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+14M sh	$18.74	+$262M	570,073,879
2025-10-21	SMMTSummit Therapeutics Inc.P Purchase	Director, Co-Chief Executive Officer, 10% Owner	PPurchase	+26.7K sh	$18.74	+$500K	76,680
2025-09-11	SMMTSummit Therapeutics Inc.P Purchase	Director, Co-Chief Executive Officer, 10% Owner	PPurchase	+5,000 sh	$18.07	+$90.4K	556,093,090
2025-09-10	PLSEPULSE BIOSCIENCES, INC.P Purchase	Director, 10% Owner	PPurchase	+34.7K sh	$14.66	+$508K	47,551,200
2025-09-10	SMMTSummit Therapeutics Inc.P Purchase	Director, Co-Chief Executive Officer, 10% Owner	PPurchase	+333K sh	$17.68	+$5.89M	556,088,090
2025-08-15	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+30K sh	—	—	30,000
2025-08-15	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+20.8K sh	—	—	20,792
2025-05-30	SMMTSummit Therapeutics Inc.M Exercise/Conversion	Director, Co-Chief Executive Officer, 10% Owner	MExercise/Conversion	+74.5K sh	$2.64	+$197K	555,754,696
2025-05-30	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, Co-Chief Executive Officer, 10% Owner	MExercise/Conversion	−74.5K sh	—	—	0
2025-04-29	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+9.59M sh	—	—	9,590,558
2025-04-29	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+1.04M sh	—	—	1,040,000
2025-04-29	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+400K sh	—	—	400,000
2025-04-08	SMMTSummit Therapeutics Inc. · Warrant (right to buy)X Exercise of In-Money	Director, Co-Chief Executive Officer, 10% Owner	XExercise of In-Money	+3.99M sh	—	—	0
2025-04-08	SMMTSummit Therapeutics Inc.X Exercise of In-Money	Director, Co-Chief Executive Officer, 10% Owner	XExercise of In-Money	+3.99M sh	$1.58	+$6.3M	555,680,151
2025-01-02	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+10.7K sh	$9.18	+$98.4K	10,724
2024-12-18	PLSEPULSE BIOSCIENCES, INC.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+5.19M sh	$11.00	+$57.1M	47,516,541
2024-12-18	PLSEPULSE BIOSCIENCES, INC. · Warrants (right to buy)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−24.7K sh	—	—	0
2024-12-18	PLSEPULSE BIOSCIENCES, INC.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+69K sh	$11.00	+$759K	630,109
2024-12-18	PLSEPULSE BIOSCIENCES, INC. · Warrants (right to buy)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−34.5K sh	—	—	0
2024-12-18	PLSEPULSE BIOSCIENCES, INC. · Warrants (right to buy)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−2.59M sh	—	—	0
2024-12-18	PLSEPULSE BIOSCIENCES, INC. · Warrants (right to buy)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−2.59M sh	—	—	0
2024-12-18	PLSEPULSE BIOSCIENCES, INC.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+49.3K sh	$11.00	+$542K	450,189
2024-12-18	PLSEPULSE BIOSCIENCES, INC. · Warrants (right to buy)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−24.7K sh	—	—	0
2024-12-18	PLSEPULSE BIOSCIENCES, INC. · Warrants (right to buy)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−34.5K sh	—	—	0
2024-12-13	PLSEPULSE BIOSCIENCES, INC.P Purchase	Director, 10% Owner	PPurchase	+55.3K sh	$17.18	+$949K	42,328,717
2024-12-12	PLSEPULSE BIOSCIENCES, INC.P Purchase	Director, 10% Owner	PPurchase	+45.4K sh	$17.13	+$778K	42,273,461
2024-12-11	PLSEPULSE BIOSCIENCES, INC.P Purchase	Director, 10% Owner	PPurchase	+6,054 sh	$16.74	+$101K	42,178,057
2024-12-11	PLSEPULSE BIOSCIENCES, INC.P Purchase	Director, 10% Owner	PPurchase	+50K sh	$17.42	+$871K	42,228,057
2024-09-12	PLSEPULSE BIOSCIENCES, INC.P Purchase	Director, 10% Owner	PPurchase	+145K sh	$14.41	+$2.09M	47,709,140
2024-09-11	PLSEPULSE BIOSCIENCES, INC.P Purchase	Director, 10% Owner	PPurchase	+12.8K sh	$14.77	+$189K	47,564,000
2024-09-11	SMMTSummit Therapeutics Inc.A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+3.33M sh	$22.70	+$75.5M	551,695,096
2024-07-03	PLSEPULSE BIOSCIENCES, INC. · Warrant (right to buy)P Purchase	Director, 10% Owner	PPurchase	+2.59M sh	—	—	2,593,912
2024-07-03	PLSEPULSE BIOSCIENCES, INC. · Warrant (right to buy)P Purchase	Director, 10% Owner	PPurchase	+34.5K sh	—	—	34,510
2024-07-03	PLSEPULSE BIOSCIENCES, INC.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+5.19M sh	—	—	42,172,003
2024-07-03	PLSEPULSE BIOSCIENCES, INC. · Warrant (right to buy)P Purchase	Director, 10% Owner	PPurchase	+2.59M sh	—	—	2,593,912
2024-07-03	PLSEPULSE BIOSCIENCES, INC.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+49.3K sh	—	—	400,877
2024-07-03	PLSEPULSE BIOSCIENCES, INC.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+69K sh	—	—	561,089
2024-07-03	PLSEPULSE BIOSCIENCES, INC. · Warrant (right to buy)P Purchase	Director, 10% Owner	PPurchase	+34.5K sh	—	—	34,510
2024-07-03	PLSEPULSE BIOSCIENCES, INC. · Warrant (right to buy)P Purchase	Director, 10% Owner	PPurchase	+24.7K sh	—	—	24,656
2024-07-03	PLSEPULSE BIOSCIENCES, INC. · Warrant (right to buy)P Purchase	Director, 10% Owner	PPurchase	+24.7K sh	—	—	24,656
2024-06-06	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+16.2K sh	—	—	16,247
2024-06-06	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+20K sh	—	—	20,000

Recent filings

Accepted (ET)
Jun 154
DUGGAN ROBERT W0001437749-26-020717
SEC(opens sec.gov)
Jun 124
DUGGAN ROBERT W0001055919-26-000007
SEC(opens sec.gov)
Jun 44
DUGGAN ROBERT W0001055919-26-000005
SEC(opens sec.gov)
May 154/A
DUGGAN ROBERT W0001437749-26-017478
SEC(opens sec.gov)
May 114
DUGGAN ROBERT W0001437749-26-016188
SEC(opens sec.gov)
Jan 64
DUGGAN ROBERT W0001055919-26-000003
SEC(opens sec.gov)
Oct 234
DUGGAN ROBERT W0001055919-25-000003
SEC(opens sec.gov)
Sep 124
DUGGAN ROBERT W0001437749-25-028988
SEC(opens sec.gov)
Sep 114
DUGGAN ROBERT W0001599298-25-000142
SEC(opens sec.gov)
Aug 194
DUGGAN ROBERT W0001437749-25-027394
SEC(opens sec.gov)
Jun 24
DUGGAN ROBERT W0001599298-25-000106
SEC(opens sec.gov)
May 14
DUGGAN ROBERT W0001599298-25-000093
SEC(opens sec.gov)

Companies

Address

C/O PULSE BIOSCIENCES, INC. 3957 POINT EDEN WAY

HAYWARD, CA, 94545